RecruitingPhase 4NCT05841758
Hydroxychloroquine as a Steroid-sparing Agent in Extrapulmonary Sarcoidosis
Studying Sarcoidosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Hospices Civils de Lyon
- Intervention
- Hydroxychloroquine(drug)
- Enrollment
- 140 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2024 – 2029
Study locations (21)
- Service de Médecine Interne Infectiologie Aïgue Polyvalente- Hôpital Henri Duffaud, Avignon, France
- Service de Pneumologie - Hôpital Avicenne, Bobigny, France
- Service de medecine interne - Hôpital Henri Mondor, Créteil, France
- Service de Médecine Interne et Immunologie Clinique - CHU Dijon Bourgogne, Dijon, France
- Service de medecine interne - Hôpital Claude Huriez, Lille, France
- Service de medecine interne - Hôpital Duputryen, Limoges, France
- Service de médecine interne - Hôpital de la Croix Rousse, Lyon, France
- Service de médecine interne - Hôpital Edouard Herriot, Lyon, France
- Service de médecine interne - Hôpital Lyon Sud, Lyon, France
- Service de médecine interne - Centre Hospitalier Saint Joseph Saint Luc, Lyon, France
- Service de medecine interne - Hôpital Saint Eloi, Montpellier, France
- Service de medecine interne - Hôpital Hôtel Dieu, Nantes, France
- Service de médecine interne - Hôpital Lariboisière, Paris, France
- Service de medecine interne 2- Hôpital de la Pitié-Salpétrière, Paris, France
- Hôpital Cochin - Médecine interne, Paris, France
- +6 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05841758 on ClinicalTrials.govOther trials for Sarcoidosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07498842Corticosteroid Tapering in SarcoidosisRoyal Brompton & Harefield NHS Foundation Trust
- RECRUITINGNANCT07073963Virtual Patient Groups for Sarcoidosis Associated FatigueThe Cleveland Clinic
- RECRUITINGPHASE2NCT07159074Repurposing Tilmanocept for Cardiac SarcoidosisDuke University
- RECRUITINGPHASE2NCT06978725A Phase 2 Study of the Safety and Efficacy of Brepocitinib in Adults With Cutaneous Sarcoidosis (BEACON)Priovant Therapeutics, Inc.
- RECRUITINGNANCT05954507Evaluation of the Prognostic Value of PET/MRI in Cardiac SarcoidosisAssistance Publique - Hôpitaux de Paris
- RECRUITINGPHASE2NCT06660732Rilonacept in Subjects With Cardiac SarcoidosisMayo Clinic
- RECRUITINGNANCT07384897Immune Cells Role in Lung Cancer and Their Use in Anticancer Immunotherapies and Inflammatory Lung DiseaseUniversité Catholique de Louvain
- RECRUITINGNCT06510894Diagnostic Utility of SGLT1/2 Inhibition to Facilitate Myocardial Glucose SuppressionUniversity of Pennsylvania